Skip to content

Surgical outcomes of penetrating canaloplasty in the treatment of patients with refractory glaucoma

Surgical outcomes of penetrating canaloplasty in the treatment of patients with refractory glaucoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020511
Enrollment
Unknown
Registered
2019-01-04
Start date
2015-06-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory glaucoma

Interventions

Case series:Penetrating canaloplasty

Sponsors

The Eye Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Neonatal vascular glaucoma, iris corneal endothelial syndrome, traumatic glaucoma, secondary glaucoma caused by uveitis, childhood glaucoma, glaucoma after repeated filtration surgery failed, and other refractory glaucoma; 2. Patients with >21mmHg intraocular pressure and progressive visual impairment at the maximum dose

Exclusion criteria

Exclusion criteria: 1. The subjects with eye infections 2 weeks before recruitment; 2. Patients with severe cardiovascular, respiratory or other systemic diseases who cannot tolerate glaucoma surgery; 3. Pregnant women or breast feeding women; 4. Subjects participated in other clinical trials within 30 days; 5. Refusal to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Intraocular pressure;antiglaucoma medications;

Countries

China

Contacts

Public ContactYuanbo Liang

The Eye Hospital of Wenzhou Medical University

yuanboliang@126.com+86 18257748686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026